The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to Deploy Digital Pathology for Diagnostics in the Cloud with Amazon Web Services (AWS)

Indica Labs today announces that the Institute of Tissue Medicine and Pathology at the University of Bern has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc.

ZeOmega Named a Major Player in 2024 IDC MarketScape for U.S. Health Plan Prior Authorization Solutions

ZeOmega®, the leading population health management organization, today announced that it was recognized as a Major Player in the IDC MarketScape: U.S. Health Plan Prior Authorization Solutions 2024 Vendor Assessment (doc #US51810824, November 2024) report. ZeOmega believes this distinction reflects its innovative use of AI and other technologies to optimize prior authorization processes and meet interoperability standards, empowering health plans to improve provider satisfaction and member outcomes with faster, more efficient approvals.

Symbiosis Expands Business Development Team with Two Key Commercial Appointments in the US

DNAnexus and Panomics Join Forces to Deliver Comprehensive, Interactive Multi-omics Data Solutions for Biopharma Organizations

DNAnexus and Panomics to Deliver Multi-omics Data Solutions for Biopharma

Certis Oncology Solutions Unveils CertisOI Assistant™ - Bringing Chatbot Efficiency to Oncology Research

The first AI-driven assistant of its kind in the preclinical oncology space, CertisOI Assistant enables users to query vast datasets, perform complex computational analyses, and visualize drug efficacy predictions—all through a seamless, natural language interface. With this solution, Certis is redefining how researchers interact with oncology data, promising to accelerate the development of new cancer therapies and the realization of personalized medicine. Highly specialized for oncology research, CertisOI Assistant’s conversational interface and integration with CertisAI, Certis’ proprietary AI/ML platform allow cancer scientists to easily query both public and proprietary tumor model datasets; perform complex ad hoc analyses; convert results into downloadable tables, charts, and graphs for actionable insights, and leverage AI-generated drug response predictions to inform critical research decisions.

evitria Partners with Sapio Sciences to Streamline Antibody Workflow Management and Reporting

Sapio Sciences, the science-aware™ lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.

Laudio recognized as one of Modern Healthcare’s Best in Business

Phastar Scoops Prestigious 2024 Scrip Award

Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards.

Oxford Nanopore and UK Biobank to create world’s first epigenetic dataset targeting the causes of cancer, dementia, complex disease

Oxford Nanopore Technologies announced a new collaboration with UK Biobank to create the world’s first comprehensive, large-scale epigenetic dataset.

Intelliguard and Codonics Partner to Strengthen Patient Safety

Intelliguard, a provider of medication management and data-intelligence solutions, announces a strategic partnership with Codonics, a global leader in healthcare technology offering cutting-edge solutions for patient safety. This partnership allows Intelliguard’s Mira Care Station customers to leverage the Codonics Safe Label System (SLS) for fast, compliant, and standardized syringe labeling, ensuring a closed-loop medication process in operating rooms.

CB Insights Recognizes Proscia Among Most Promising Digital Health Companies Of 2024

Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes.

New digital health fund KELES appoints three expert advisors to accelerate healthcare growth across Europe

KELES, venture capital firm led by digital health investors David Buller and Laurent Van Lerberghe, appoints three expert advisors to strengthen its leadership team and accelerate progress in European digital health innovation.

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market

Abselion has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market.

Cotiviti Welcomes Seasoned Technology Executive Suvajit Gupta as Chief Technology Officer

Biocair strengthens its customer focus in 2024 and prepares for another year of growth

Duke Street Bio Announces First Patient Dosed in Phase I Trial with DSB2455, a Next Generation PARP1 Selective Inhibitor for the Treatment of Solid Tumours

Duke Street Bio Ltd has announced that the first patient has been dosed with its highly selective PARP1 inhibitor, DSB2455, in a Phase 1 clinical trial after European Medicines Agency approval earlier this year.

Capricor Therapeutics Showcases Groundbreaking Exosome Therapy Platform at 2024 AAEV Annual Meeting

Capricor Therapeutics announced that it would introduce the abstract about the pre-clinical data, giving a spotlight on the therapeutic potential of its StealthX exosome platform technology at the 2024 American Association of Extracellular Vesicles Annual Meeting in Texas.

Clinion Wins 2024 SCDM Innovation Award for Excellence in Clinical Data Science

Clinion’s groundbreaking platform is revolutionizing clinical trials, demonstrating how cutting-edge technology is expediting the journey of new therapies to market.

India Charts BioE3 Policy to Propel Advanced Biomanufacturing

The government announced the BioE3 (Biotechnology for Economy, Environment and Employment) policy, a strategic plan to take India to the next era of industrialization through advanced biomanufacturing. Enhancing India’s biomanufacturing capabilities by integrating science, technology, engineering, and manufacturing will enable institutions, universities, startups, and industries in India to participate in innovation, thereby supporting the growth of the upstream bioprocessing market.

Tillotts Pharma partners with Pioneer for the marketing and distribution of Tillotts` product Asacol® in the People’s Republic of China

Tillotts Pharma AG and Pioneer Pharma (Hong Kong) Co., Limited has announced the signing of an exclusive agreement covering the distribution and marketing of Tillotts’ product Asacol® Tablets 800mg in the mainland of the People’s Republic of China.